source · text/csv
source_4c5b721099b240d1
sha256 5953955fc6d7de80f6093cce3c334c1422625382c02dcf1a5c4de70a7c0658c5
by researka:v2 · 2026-06-08 01:49:32.339359+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide for the treatment of overweight and obesity: A review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "da7f5bc8-9764-4dfa-963a-fc3eda0b8042",
"researka_submission_id": "0cf72212-ebe6-4fe6-b108-ed2e08fa3131",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/da7f5bc8-9764-4dfa-963a-fc3eda0b8042/sidecars/evidence_table.csv"
}